Skip to main navigation
Skip to search
Skip to main content
University of Kentucky Home
LOGIN & Help
Link opens in a new tab
English
Español
Search content at University of Kentucky
Home
Research units
Researchers
Projects & Grants
Research Output
Facilities & Equipment
Honors & Awards
Activities
Dyslipidemia in patients with chronic kidney disease
Matthew R. Hager
, Archana D. Narla
, Lisa R. Tannock
Internal Medicine
Barnstable Brown Diabetes Center
College of Medicine
Research output
:
Contribution to journal
›
Review article
›
peer-review
170
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Dyslipidemia in patients with chronic kidney disease'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Dyslipidemia
100%
Chronic Kidney Disease
100%
Cardiovascular Disease
33%
Clinical Trial
22%
Statin
22%
Deterioration
11%
Triacylglycerol
11%
Kidney Function
11%
Immunology and Microbiology
Lipid Level
100%
Triacylglycerol Level
100%
Kidney Function
100%
Pharmacology, Toxicology and Pharmaceutical Science
Chronic Kidney Failure
100%
Dyslipidemia
100%
Cardiovascular Disease
33%
Clinical Trial
22%
Statin (Protein)
11%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
11%
Triacylglycerol
11%
Deterioration
11%
Biochemistry, Genetics and Molecular Biology
Dyslipidemia
100%
Lipid
33%
Clinical Trial
33%
Statin
33%
Kidney Function
16%
Lipid Level
16%
Triacylglycerol Level
16%